monobromobimane has been researched along with gastrodin in 1 studies
| Studies (monobromobimane) | Trials (monobromobimane) | Recent Studies (post-2010) (monobromobimane) | Studies (gastrodin) | Trials (gastrodin) | Recent Studies (post-2010) (gastrodin) |
|---|---|---|---|---|---|
| 199 | 1 | 42 | 302 | 3 | 234 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Liang, YL; Mao, LS; Qiu, CW; Zhu, HF | 1 |
1 other study(ies) available for monobromobimane and gastrodin
| Article | Year |
|---|---|
Gastrodin alleviates cisplatin nephrotoxicity by inhibiting ferroptosis via the SIRT1/FOXO3A/GPX4 signaling pathway.
Topics: Acute Kidney Injury; Animals; Cell Line; Cisplatin; Ferroptosis; Humans; Mice; Signal Transduction; Sirtuin 1; Sirtuins | 2024 |